Although not always mandatory, prescription is recommended for safe use and dosing
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Can AOD-9604 target fat cells in people who are already lean
All that you need to do is to contact a certified practitioner
(5) This may be due to the potential role of AOD 9604 in cellular differentiation processes and, potentially, in the synthesis of proteins important for tissue repair
The effectiveness period of these injections varies based on individual factors and metabolism rates, and may last between one to two weeks in the system [12]